The Impact of the COVID-19 Pandemic on Urology Practice in Indonesia: A Nationwide Survey
5 January 2019
Purpose. This study aimed to investigate the impact of COVID-19 on urology practice in Indonesia.
Material and Methods. This was a cross-sectional study using web-based questionnaire (Survey Monkey), which was distributed and collected within a period of three weeks. All practicing urologists in Indonesia were sent an e-questionnaire link via E-mail, WhatsApp Messenger application, and/or short message service, and the chief of residents in each urology centre distributed the e-questionnaire to urology residents.
Results. The response rate was 369/485 (76%) among urologists and 220/220 (100%) among urology residents. Less than 10 percent of the responses in each section were incomplete. There are 35/369 (9.5%) of urologists and 59/220 (26.8%) of urology residents had been suspected as COVID-19 patients, of whom seven of them were confirmed to be COVID-19 positive. The majority of urologists (66%) preferred to continue face-to-face consultations with a limited number of patients, and more than 60% of urologists preferred to postpone the majority (66%) or all elective surgery. Most urologists also chose to postpone elective surgery in patient with COVID-19-related symptoms and patient who required post-operative ICU-care. Urologist and urology residents reported high rates of using personal protective equipment, except for medical gowns and N95 masks, which were in short supply. Several uro-oncology surgeries were considered to be the top priority for Indonesian urologist during COVID-19 epidemic period.
Conclusion. The COVID-19 pandemic has caused a decline in urology service in both outpatient clinic and surgery services with uro-oncological procedure as a priority to conduct.
- COVID-19, urology, elective surgery, personal protective equipment
How to Cite
2. WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 5 April 2020.
3. Kementerian Kesehatan Republik Indonesia. Dashboard data kasus COVID-19 di Indonesia. https://www.kemkes.go.id/article/view/20031900002/Dashboard-Data-Kasus-COVID-19-di-Indonesia.html. Accessed 2 May 2020.
4. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–36.
5. Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, et al. Molecular diagnosis of a novel Coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;555:549–55.
6. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
7. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020. doi: 10.1016/j.jaut.2020.102433
8. Lu S, Lin J, Zhang Z, Xiao L, Jiang Z, Chen J, et al. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. 2020;2019:0–3.
9. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63:706–11.
10. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125. Accessed 26 May 2020.
11. European Centre for Disease Prevention and Control. Infection prevention and control for COVID-19 in healthcare setting - first update. 12 March 2020. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-infection-prevention-and-control-healthcare-settings-march-2020.pdf. Accessed 26 May 2020.
12. Royal College of Surgeons. Good practice for surgeons and surgical teams. https://www.rcseng.ac.uk/standards-and-research/standards-and-guidance/good-practice-guides/coronavirus/. Accessed 26 May 2020
13. Gravas S, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, et al. Impact of COVID-19 on urology practice: a global perspective and snapshot analysis. J Clin Med. 2020;9(6):1730.
14. Gravas S, Fournier G, Oya M, Summerton D, Mario R, Chlosta P, et al. Prioritising urological surgery in the COVID-19 era : a global reflection on guidelines. Eur Urol Focus. 2020. doi: 10.1016/j.euf.2020.06.006.
15. Isbaniah F, Kusumowardhani D, Sitompul D, Susilo A, Wihastuti R, Setyawaty V, et al. Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19). Kementrian Kesehatan Republik Indonesia. https://corona.ntbprov.go.id/storage/dokumen/pedoman-covid-19.pdf. Accessed 26 May 2020.
16. Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020. doi: 10.5603/CJ.a2020.0055.
17. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, De Nunzio C, et al. Urology practice during COVID-19 pandemic. Minerva Urol Nefrol. 2020. doi: 10.23736/S0393-2249.20.03846-1.
18. Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43.
19. Badan Pusat Statistik. Indikator strategis nasional. https://www.bps.go.id/QuickMap?id=0000000000. Accessed 7 May 2020.
20. Kementerian Kesehatan Republik Indonesia. Situasi terkini perkembangan Coronavirus Disease (COVID-19). https://covid19.kemkes.go.id/situasi-infeksi-emerging/info-corona-virus/situasi-terkini-perkembangan-coronavirus-disease-covid-19-6-mei-2020/#.XrQali-cZ0t. Accessed 7 May 2020.
21. Our World in Data. Total COVID-19 tests per 1,000 people. https://ourworldindata.org/grapher/full-list-cumulative-total-tests-per-thousand?country=IND+IDN+ITA+ZAF+KOR+USA+DNK+NZL+CAN+MYS+SGP. Accessed 7 May 2020.
22. Puliatti S, Eissa A, Eissa R, Amato M, Mazzone E, Dell’Oglio P, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int. 2020. doi: 10.1111/bju.15071.
23. Amparore D, Claps F, Cacciamani GE, Esperto F, Fiori C, Liguori G, et al. Impact of the COVID-19 pandemic on urology residency training in Italy. Minerva Urol Nefrol. 2020. doi: 10.23736/S0393-2249.20.03868-0.
24. Bialek S, Boundy E, Bowen V, Chow N, Cohn A, Dowling N, et al. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-march 16, 2020. Morb Mortal Wkly Rep. 2020;69:343–6.
25. Liu Y, Mao B, Liang S, Yang J, Lu H, Chai Y, et al. Association between age and clinical characteristics and outcomes of Coronavirus Disease 2019. Eur Respir J. 2020. doi: 10.1183/13993003.01112-2020.
26. Rasyid N, Atmoko W, Daryanto B, Wahyudi I, Hamid ARAH. Rekomendasi pelayanan urologi terkait COVID-19. 1st ed. Rasyid N, Atmoko W, Daryanto B, Wahyudi I, Hamid ARAH, editors. Jakarta: Ikatan Ahli Urologi Indonesia; 2020.
27. Marcelo A, Ganesh J, Mohan J, Kadam DB, Ratta BS, Kulatunga G, et al. Governance and management of national Telehealth programs in Asia. Stud Health Technol Inform. 2015;209:95–101.
28. Varghese S, Scott RE. Categorizing the Telehealth policy response of countries and their implications for complementarity of Telehealth policy. Telemed J e-Health. 2004;10:61–9.
29. Campi R, Amparore D, Capitanio U, Checcucci E, Salonia A, Fiori C, et al. Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insight from three Italian high-volume referral centres. Eur Urol. 2020;78:11-5
- Abstract Viewed: 0 times
- Just Accepted/6459 Downloaded: 0 times